Département A: Research in Drug Development (RD3)
Unit 2 : Pharmacognosy Bioanalysis and Drug Discovery
His first research interests focus on the validation of myeloperoxidase as a therapeutical target. In this context, part of his research is also dedicated to the inhibition of myeloperoxidase by chemical screening and rational drug design approach. Since 2008, his main task has been the development of the analytical platform of the Faculty of Pharmacy (ULB) and especially the mass spectrometry. Beside the myeloperoxidase research topic, method validations suitable for the pharmaceutical and biomedical researches are the main part of his actual activities: oxidized peptide quantifications, glycobiology, proteomics, metabolomics, lipidomics, small molecules analysis...
TOP 10 ARTICLES:
Professor Pierre Van Antwerpen - Dean of the Faculty of Pharmacy (ULB)
Pierre VAN ANTWERPEN
Dean of the Faculty of Pharmacy (ULB) (2015-2017).
Vice-Dean of the Faculty of Pharmacy of (ULB) (2013-2015).
Professor at the Faculty of Pharmacy of (ULB) (2014- ).
Assistant-professor at the Faculty of Pharmacy (ULB) (2008-2014)
Post-Doc and Assistant in the Laboratory of Organic Pharmaceutical Chemistry (Faculty of Pharmacy, ULB) (2006-2008)
Assistant in the Laboratory of Organic Pharmaceutical Chemistry (Institute of Pharmacy, ULB) (2000-2006).
2001-2006 PhD in pharmaceutical sciences (Title: “Antioxidant properties of several therapeutical molecules: focus on the Myeloperoxidase/Hydrogen Peroxide/Chloride System”), Institude of Pharmacy (ULB).
2000 Diplome d’étude approfondie en sciences de la santé” at the Institute of Pharmacy (ULB).
1996-2000 Pharmacist with “grande distinction” at the Institute of Pharmacy of the Université Libre de Bruxelles (ULB, Belgium)